We reported that BA promoted the accumulation of KEAP1 and inhibited NRF2 and HO-1 in vitro and in vivo models, impeding KEAP1-NRF2/HO-1 signaling in NSCLC. The gene discussed is NFE2L2; the disease is non-small cell lung carcinoma.